1
|
Malkhasyan VA, Makhmudov TB, Gilfanov YS, Semenyakin IV, Sukhikh SO, Pushkar DY. [Effect of a simple kidney cyst on renal function]. Urologiia 2023:75-81. [PMID: 37850285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/19/2023]
Abstract
INTRODUCTION Renal cysts are a common disease that occurs at a rate of 7-10%. Currently there are no clinical recommendations for the treatment of patients with simple renal cysts. In the current literature there is some evidence that a simple renal cyst has negative effects on renal function. Decreased renal function occurs due to partial atrophy and loss of the renal parenchyma (in the "crater" area at the base of the cyst) caused by compression. Therefore, the efforts to analyze the effect of simple kidney cysts on kidney function and identify the characteristics of the cyst that affect renal function to determine the indications for surgical treatment remains a substantial task. The aim of the study was to analyze the effect of simple renal cysts on renal function, to investigate the relationship between cyst size, atrophied parenchyma volume, and renal function, and to determine indications for surgical treatment of simple renal cysts. MATERIALS AND METHODS We conducted a prospective cohort study. The study included 109 patients with simple renal cysts. Patients with a solitary cyst of the right or left renal kidney, grade I-II according to Bosniak classification, were included in the study. The estimated glomerular filtration rate (eGFR) of the patients was calculated using various formulas. A contrast CT scan of the urinary tract was also performed to determine the maximum size of the cyst, calculate the volume of the renal parenchyma, and the volume of the lost (atrophied) parenchyma. Patients underwent renal scintigraphy with calculation of total GFR and split renal function. We analyzed the symmetry of the function of both kidneys by comparing the GFR of the affected and healthy kidneys, analyzed the relationship between the presence of a kidney cyst and a decrease in GFR, between the maximum size of a renal cyst and a decrease in its function compared with that of a healthy kidney. We also analyzed the correspondence of total GFR values obtained in renal scintigraphy and GFR values calculated according to the formulas. RESULTS Data from 109 patients were available for analysis; the mean blood creatinine was 87.4 mol/L. The median maximum cyst size was 80 mm. The median baseline volume of the affected kidney parenchyma was 174 ml, the median volume of the lost parenchyma was 49 ml, and the median proportion of the lost parenchyma was 28%. The median total GFR was 77.07 ml/min. The median GFR of the healthy kidney was 45.49 mL/min, and the median GFR of the kidney affected by the cyst was 34.46 mL/min. The median difference in GFR of the healthy and affected kidney units was 11 mL/min and was statistically significant. Comparison of the eGFR values obtained by the formulas with the reference values of GFR obtained by scintigraphy showed that the Cockcroft-Gault formula with standardization on the body surface area calculated closest eGFR values to the reference ones. Correlation analysis revealed a statistically significant association between the proportion of lost parenchyma volume and the maximum cyst size: =0.37 with 95% CI [0.20; 0.52] (p-value = 0). A multivariate logistic regression model revealed that a statistically significant factor influencing the probability of a significant decrease in GFR was the percent of lost renal parenchyma volume (OR=1,13; =0). CONCLUSIONS Our study showed that growth of renal cysts associated with renal parenchyma atrophy and decrease of GFR of the affected kidney. An increase in the volume of atrophied parenchyma leads to the decrease in GFR of the affected kidney. The obtained data suggest that performing dynamic renal scintigraphy to assess the decrease in affected renal function and determine the indications for surgical treatment of renal cysts is a reasonable recommendation. According to the results of the study, the loss of 20% of the renal parenchyma can be considered an indication for renal scintigraphy. The Cockcroft-Gault formula with standardization on the body surface area allows to calculate closest GFR values to those obtained by scintigraphy and, therefore, can be recommended as the optimal formula for calculating eGFR in daily clinical practice.
Collapse
Affiliation(s)
- V A Malkhasyan
- S.I.Spasokukotsky City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russia
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- MDDC SberMEDI LLC, Moscow, Russia
- Medsi group JSC, Moscow, Russia
| | - T B Makhmudov
- S.I.Spasokukotsky City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russia
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- MDDC SberMEDI LLC, Moscow, Russia
- Medsi group JSC, Moscow, Russia
| | - Yu Sh Gilfanov
- S.I.Spasokukotsky City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russia
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- MDDC SberMEDI LLC, Moscow, Russia
- Medsi group JSC, Moscow, Russia
| | - I V Semenyakin
- S.I.Spasokukotsky City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russia
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- MDDC SberMEDI LLC, Moscow, Russia
- Medsi group JSC, Moscow, Russia
| | - S O Sukhikh
- S.I.Spasokukotsky City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russia
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- MDDC SberMEDI LLC, Moscow, Russia
- Medsi group JSC, Moscow, Russia
| | - D Y Pushkar
- S.I.Spasokukotsky City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russia
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- MDDC SberMEDI LLC, Moscow, Russia
- Medsi group JSC, Moscow, Russia
| |
Collapse
|
2
|
Apolikhina IA, Teterina TA, Arefieva OA, Kasyan GR, Krivoborodov GG, Romikh VV, Mirkin YB, Fomenko OY, Saidova AS, Yarotskaya EL, Gorodnova EA, Pushkar DY, Apolikhin OI, Gadzhieva ZK, Korshunova ES, Filippova ES, Kuzmin IV, Shornikov PV. [Language, cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire in patients with overactive bladder]. Urologiia 2023:31-39. [PMID: 37850278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/19/2023]
Abstract
AIM To perform language and cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire among patients with overactive bladder (OAB), proposed as an effective tool for assessing the severity of symptoms and the efficiency of treatment in clinics of the Russian Federation. MATERIALS AND METHODS In accordance with the protocols for carrying out such studies, the procedure of standardized forward-backward translation of the OABSS questionnaire was performed. Further, the intermediate Russian-language version was applied to 15 patients with subsequent correction of deficiencies and approval of the final Russian-language version of the questionnaire. In total, the study group included 176 patients of both sexes with OAB symptoms who filled out the questionnaire twice (test-retest) with an interval of 10-14 days. RESULTS Based on the statistical analysis (Cronbach's alpha = 0.961), there was a significant degree of internal consistency of the sample. This fact is also supported by the very high retest reliability of the questionnaire (ICC >0.9). CONCLUSION Our data showed that the Russian version of the OABSS questionnaire is a reliable and valid tool for subjective assessment of the severity of OAB symptoms.
Collapse
Affiliation(s)
- I A Apolikhina
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - T A Teterina
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - O A Arefieva
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - G R Kasyan
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - G G Krivoborodov
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - V V Romikh
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - Ya B Mirkin
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - O Yu Fomenko
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - A S Saidova
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - E L Yarotskaya
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - E A Gorodnova
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - D Yu Pushkar
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - O I Apolikhin
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - Z K Gadzhieva
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - E S Korshunova
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - E S Filippova
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - I V Kuzmin
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| | - P V Shornikov
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation, Moscow, Russia
- FGAOU VO Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia, Moscow, Russia
- International Medical Center URO-PRO, Krasnodar, Russia
- FGBU Ryzhikh State Scientific Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russia
- FGBNU Research Center of Neurology, Moscow, Russia
- FGBU Central state medical academy of Administrative Directorate of the President of Russian Federation, Moscow, Russia
- FGBOU VO Ural State Medical University of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia
- Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, Saint Petersburg, Russia
- FGBOU VO Kuban State Medical University of Minzdrav of Russia, Krasnodar, Russia
- NIIOZMM DZM, Moscow, Russia
| |
Collapse
|
3
|
Govorov AV, Vasilyev AO, Alaverdyan AI, Kolontarev KB, Pushkar DY. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One]. Urologiia 2023:83-89. [PMID: 37401710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 07/05/2023]
Abstract
INTRODUCTION Prostate cancer (PCa) is the second most commonly diagnosed malignant tumor in men after lung cancer and is the fifth leading cause of death worldwide. In November 2019, the spectrum of alternative treatment for PCa was added by a novel minimally invasive method, namely high-intensity focused ultrasound (HIFU) using the latest Focal One machine (with the possibility of combining intraoperative ultrasound and preoperative MRI data). MATERIALS AND METHODS During the period from November 2019 to November 2021, HIFU using Focal One device (manufactured by EDAP, France) was performed in 75 patients with PCa. Total ablation was done in 45 cases, while 30 patients undergone to focal prostate ablation. The average age of the patients was 62.7 (51-80) years, the total PSA level was 9.3 (3.2-15.5) ng/ml and the prostate volume was 32.0 (11-35) cc. The maximum urinary rate was 13.3 (6.3-36) ml/s, IPSS score was 7 (3-25) points, IIEF-5 score was 18 (4-25). Clinical stage c1N0M0 was diagnosed in 60 patients, 1bN0M0 in 4 patients, 2N0M0 in 11 patients. In 21 cases, transurethral resection of the prostate was performed within 4-6 weeks prior to total ablation. Before surgery, all patients underwent magnetic resonance imaging (MRI) of the pelvis with intravenous contrast and PIRADS V2 assessment. MRI data were used intraoperatively for precision planning of the procedure. RESULTS In all patients, the procedure was performed under endotracheal anesthesia in accordance with the technical recommendations of the manufacturer. Prior to surgery, a silicone urethral catheter of 16 or 18 Ch was placed. The average duration of the intervention was 101 (56-147) minutes. The postoperative period was uneventful in all cases.Patients received antibiotic therapy via parenteral route for 4 days, followed by oral administration for another 10 days, as well as alpha-blockers (at least 1 month after procedure). After removal of urethral catheter on the 4th day, all patients started to void. In 9 cases there was acute urinary retention in the evening and in 4 patients in the next morning, requiring temporary bladder catheterization. A year after the procedure, 53 patients were fully examined: the average total PSA level in patients who underwent total ablation (n=53) was 0.96+/-0.11 ng/ml, the IPSS score was 6.9+/-0,6 points (no difference compared to baseline). Follow-up biopsy revealed PCa in 6 patients; in other cases, prostate fibrosis was determined. CONCLUSIONS HIFU in patients with localized PCa using image-guided robotic HIFU (Focal One) is promising and feasible. This method has shown good oncological results with a short follow-up period. It is advisable to carry out further prospective analysis.
Collapse
Affiliation(s)
- A V Govorov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| | - A O Vasilyev
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| | - A I Alaverdyan
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| | - K B Kolontarev
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| | - D Y Pushkar
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| |
Collapse
|
4
|
Pushkar DY, Loran OB, Bernikov AN. [The influence of alfuzosin monotherapy on the sexual function of patients with benign prostatic hyperplasia in real clinical practice (results of a Russian multicenter study)]. Urologiia 2022:21-29. [PMID: 36625609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
INTRODUCTION The current armamentarium of drugs for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) is diverse and includes both monotherapy and combination therapy. Indirect and limited direct comparisons have demonstrated that all alpha-1-blockers (a1-ABs) have similar efficacy when used at appropriate doses. Differences in tropism to the prostate of modern 1-ABs are largely responsible for the severity of their side effects, mainly negative influence on sexual function and cardiovascular system. AIM To evaluate the influence of Alfuprost MR 10 mg once daily on sexual function in patients with LUTS due to BPH during 3-months therapy in real clinical practice. The secondary endpoint was an effect on systolic, diastolic blood pressure (BP) and heart rate. MATERIALS AND METHODS A total of 537 men with LUTS/BPH were included in the study by urologists from 21 outpatient departments of the Russian Federation. The follow-up included 3 visits: visit of inclusion in the program of patients with a previously prescribed drug of Alfuprost MR in a dosage of 10 mg once a day (visit "0"), visit 1 at 30 days (+/-5 days) later, and visit 2 at 90 days (+/-5 days) after inclusion in the study. At each visit, evaluation of complaints and physical examination was performed. In addition, patients completed questionnaires: International prostate symptom score (IPSS) and quality of life (QoL) index; the full version of the International Index of Erectile Function (IIEF) questionnaire; the Likert scale for the patient and for the physician. Also, laboratory and instrumental studies used in routine clinical practice were recorded: total prostate specific antigen (PSA) in serum; ultrasound examination (US) of the bladder; transrectal ultrasound examination (TRUS) of the prostate; uroflowmetry (maximum urine flow rate (Qmax)); measurement of systolic and diastolic BP; measurement of heart rate. RESULTS after 3 months of therapy with Alfuprost MR in a dosage of 10 mg once a day, significant (p<0.05) improvement of all urodynamic parameters was documented, including a decrease in the average IPSS score by 55% and improvement of quality of life by 2.46 points (on the QoL index); increase of Qmax by 53%; reduction of the average postvoid residual to normal values. In addition to a significant improvement in the quality of urination, changes in sexual function were also positive. Thus, the average total IIEF score increased significantly (p<0,05) from 45.35 to 53.18 points. When considering specific domains of male sexual function, positive dynamics in all domains was noted: overall improvement of orgasm function, sexual desire, sexual satisfaction and overall sexual functioning was 11.98%, 15.14%, 19.7% and 18.46%, respectively. Hemodynamic indices remained stable during the 3-month follow-up; only clinically insignificant decrease in systolic BP by no more than 2 mm Hg during the entire follow-up period was observed. At the same time there was no influence on diastolic BP. Changes in heart rate were also clinically insignificant, averaging no more than 1 beat per minute. CONCLUSIONS The results of observational study allow to recommend Alfuprost MR as a first-line therapy for BPH, including for sexually active men and patients with various types of sexual dysfunction. Considering minimal and clinically insignificant vasodilatory effects observed during 3 months of therapy, it is possible to prescribe Alfuprost MR in a dosage of 10 mg once daily, including comorbid patients.
Collapse
Affiliation(s)
- D Yu Pushkar
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia.,Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| | - O B Loran
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia.,Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| | - A N Bernikov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia.,Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| |
Collapse
|
5
|
Akhvlediani ND, Sadchenko AV, Prilepskaya EA, Smernitsky AM, Pushkar DY. [Functional phimosis: prevalence, diagnosis and treatment in outpatient practice]. Urologiia 2022:54-58. [PMID: 36382818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
AIM To study the prevalence of functional phimosis determined during erection in patients over 18 years of age, as well as the features of its diagnosis and treatment in outpatient practice. MATERIALS AND METHODS A retrospective study that included 201 patients who underwent circumcision at a mean age of 42.7 years, was carried out. Complaints, history, initial examination and autophotography of the penis during erection were evaluated. The subjects were divided into 2 groups. The group I (n=38) included patients complaining of the inability to reveal the glans penis during erection, while in group II (n=163) men with similar complaints in a f laccid state of the penis were included. All patients underwent circumcision under local anesthesia. RESULTS The proportion of functional phimosis was 18.9%. The mean age in groups I and II was significantly different (29.47+/-8.82 and 45.6+/-19.4 years, respectively, p<0.01). In 14 (36.8%) patients of group I, a short frenulum was also diagnosed. Primary phimosis was detected in 26.3% and 14.1% of patients in groups I and II (p<0.05), respectively. The acquired phimosis was diagnosed in 73.7% and 85.9% (p<0.05) of cases, respectively. There were no concomitant diseases in patients with "functional" phimosis, while in men with "pathological" phimosis, 22.7% of patients had various comorbidities, such as diabetes mellitus, coronary heart disease, hypertension, etc. CONCLUSIONS: Among patients who visit a urologist with a diagnosis of phimosis, almost every fifth man has functional form (18.9%). For the diagnosis of the phimosis, the history taking and autophotography of the penis during erection have an important role. In this category of patients, surgical treatment can be performed on an outpatient basis.
Collapse
Affiliation(s)
- N D Akhvlediani
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
- NUZ NKC OAO RJD, Moscow, Russia
| | - A V Sadchenko
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
- NUZ NKC OAO RJD, Moscow, Russia
| | - E A Prilepskaya
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
- NUZ NKC OAO RJD, Moscow, Russia
| | - A M Smernitsky
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
- NUZ NKC OAO RJD, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
- NUZ NKC OAO RJD, Moscow, Russia
| |
Collapse
|
6
|
Malkhasyan VA, Gazimiev MA, Martov AG, Gadzhiev NK, Sukhikh SO, Pushkar DY. [Current state of metaphylaxis of urinary stones in Russian Federation]. Urologiia 2022:46-52. [PMID: 36382817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
INTRODUCTION Urolithiasis is one of the most common urological diseases in adults. Increased life expectancy of the population in developed countries, make urolithiasis topical issue and requires close attention. Due to the high risk of recurrent stone formation causing repeated surgical interventions, the issue of effective urinary stone metaphylaxis is very important today. MATERIALS AND METHODS To study the current state of the problem of urolithiasis metaphylaxis among Russian urologists, an anonymous questionnaire was applied. A 25-question questionnaire was sent to e-mail to more than 4,000 Russian urologists. A total of 1,238 specialists completed the questionnaire. The database compiled from the received responses was processed and presented with descriptive statistics in the form of tables and charts. RESULTS According to the survey, more than half of the 831 (67.1%) specialists specialized in the treatment of urolithiasis. It was noted that 626 (86%) inpatient urologists and 205 (40%) outpatient urologists specialized in the treatment of urolithiasis. Only 521 (69.6%) urologists specializing in surgical treatment of urolithiasis give a patient a stone fragment to analyze its chemical composition. At the same time, half of the respondents reported that less than 10% of patients come to them for further metaphylaxis. One of the main reasons for not analyzing the chemical composition of the stone was the fact that 877 (70,84%) specialists indicated the inaccessibility of analysis under the state guarantee program, 503 (40,63%) specialists indicated the patients satisfaction with the results of minimally invasive surgical treatment and lack of sufficient motivation for further examinations. At the same time, less than 3% of specialists can perform stone analysis within the framework of the state guaranty program. 1180 (96,8%) respondents practiced the prophylaxis of recurrent calculi formation, but only 336 (28,47%) performed comprehensive metabolic examination of all patients followed by prescription of drug therapy and appropriate diet. CONCLUSIONS Our survey revealed low involvement of urologists at the outpatient level in the process of conservative treatment and metaphylaxis of urolithiasis, low activity of urologists in performing complex metabolic study and comprehensive prevention of recurrent stone formation, low percentage of performing chemical composition analysis of stone and low activity of urologists in performing primary litholytic therapy of urate stones. Based on this analysis of the responses of most Russian urologists, it is possible to formulate recommendations to remove the obstacles to providing patients with urolithiasis with quality medical care in terms of conservative therapy and metaphylaxis of urolithiasis.
Collapse
Affiliation(s)
- V A Malkhasyan
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- I.M.Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Burnazyan SRC FMBC, FMBA of Russia, M.V. Lomonosov Medical Research and Educational Center Moscow State University, Moscow, Russia
- N.I.Pirogov High Medical Technologies Clinic, Saint Petersburg State University, Saint Petersburg, Russia
- S.I.Spasokukotsky City Clinical Hospital Moscow Healthcare Department, Moscow, Russia
| | - M A Gazimiev
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- I.M.Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Burnazyan SRC FMBC, FMBA of Russia, M.V. Lomonosov Medical Research and Educational Center Moscow State University, Moscow, Russia
- N.I.Pirogov High Medical Technologies Clinic, Saint Petersburg State University, Saint Petersburg, Russia
- S.I.Spasokukotsky City Clinical Hospital Moscow Healthcare Department, Moscow, Russia
| | - A G Martov
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- I.M.Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Burnazyan SRC FMBC, FMBA of Russia, M.V. Lomonosov Medical Research and Educational Center Moscow State University, Moscow, Russia
- N.I.Pirogov High Medical Technologies Clinic, Saint Petersburg State University, Saint Petersburg, Russia
- S.I.Spasokukotsky City Clinical Hospital Moscow Healthcare Department, Moscow, Russia
| | - N K Gadzhiev
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- I.M.Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Burnazyan SRC FMBC, FMBA of Russia, M.V. Lomonosov Medical Research and Educational Center Moscow State University, Moscow, Russia
- N.I.Pirogov High Medical Technologies Clinic, Saint Petersburg State University, Saint Petersburg, Russia
- S.I.Spasokukotsky City Clinical Hospital Moscow Healthcare Department, Moscow, Russia
| | - S O Sukhikh
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- I.M.Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Burnazyan SRC FMBC, FMBA of Russia, M.V. Lomonosov Medical Research and Educational Center Moscow State University, Moscow, Russia
- N.I.Pirogov High Medical Technologies Clinic, Saint Petersburg State University, Saint Petersburg, Russia
- S.I.Spasokukotsky City Clinical Hospital Moscow Healthcare Department, Moscow, Russia
| | - D Yu Pushkar
- A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- I.M.Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Burnazyan SRC FMBC, FMBA of Russia, M.V. Lomonosov Medical Research and Educational Center Moscow State University, Moscow, Russia
- N.I.Pirogov High Medical Technologies Clinic, Saint Petersburg State University, Saint Petersburg, Russia
- S.I.Spasokukotsky City Clinical Hospital Moscow Healthcare Department, Moscow, Russia
| |
Collapse
|
7
|
Kasyan GR, Zaitsev AV, Baibarin KA, Karasev AE, Pushkar DY. [Protective properties of urothelium and possibilities of targeted pathogenetic therapy of chronic pelvic pain: sodium pentosan polysulfate]. Urologiia 2022:91-95. [PMID: 36098600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
The review article is devoted to the possibilities of using targeted therapy for urothelial diseases, namely painful bladder syndrome (BPS). The protective structural components of the bladder mucosa, as well as their chemical features, are described in detail. Pentosanpolysulfate (PPS), being an oral heparinoid, can be used as part of pathogenetic therapy to restore the mucous membrane of the bladder. The efficacy and safety of this drug has been proven by us in a multicenter, randomized, double-blind, placebo-controlled trial. An additional assessment of the effectiveness and safety of the use of PPS in BPS was confirmed as part of our systematic review and meta-analysis. Thus, PPS is a pathogenetically sound tool in the treatment of patients with painful bladder syndrome.
Collapse
Affiliation(s)
- G R Kasyan
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow Health Department, Moscow, Russia
- Pride-Pharma, Moscow, Russia
| | - A V Zaitsev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow Health Department, Moscow, Russia
- Pride-Pharma, Moscow, Russia
| | - K A Baibarin
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow Health Department, Moscow, Russia
- Pride-Pharma, Moscow, Russia
| | - A E Karasev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow Health Department, Moscow, Russia
- Pride-Pharma, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow Health Department, Moscow, Russia
- Pride-Pharma, Moscow, Russia
| |
Collapse
|
8
|
Aitsev AV, Vasilyev AO, Shiryaev AA, Kim YA, Arefieva OA, Govorov AV, Pushkar DY. [Biofilm control in urological practice]. Urologiia 2022:81-88. [PMID: 35274866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Urinary tract infections (UTIs) have long been among the most common diseases. In the structure of the general infectious morbidity, UTIs rank second after acute respiratory viral infection. Every year, researchers note an increasing number of mutations in the genomes of bacteria that cause infectious diseases, which leads to the formation of more and more aggressive forms of pathogens. Patients with infectious diseases of the urinary system have the highest risk of biofilm formation, the frequency of which is directly proportional to the length of time the urethral catheter is located and accounts for more than half of all nosocomial infections. The presence of resistant strains of pathogenic bacteria and the development of bacterial biofilms are major problems in the treatment of urinary tract infections. The increasing number of nosocomial bacterial strains in the hospital increases the postoperative bed-day, the frequency of readmission and the number of antibacterial drugs used. In light of increasing antibacterial resistance, the use of medical resources is dramatically increasing, which ultimately leads to an increase in the cost of treatment. Along with this, the selection of resistant strains brings to the fore both the rational use of antibacterial drugs and the search for alternative methods of therapy. This review of publications on the problem of bacterial biofilm formation in urological practice demonstrates updated information on the role of enzymes, probiotics, and bacteriophages in preventing biofilm formation on various medical biomaterials, such as urethral catheters.
Collapse
Affiliation(s)
- A V Aitsev
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow, Russian Federation
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russian Federation
| | - A O Vasilyev
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow, Russian Federation
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russian Federation
| | - A A Shiryaev
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow, Russian Federation
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russian Federation
| | - Yu A Kim
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow, Russian Federation
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russian Federation
| | - O A Arefieva
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow, Russian Federation
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russian Federation
| | - A V Govorov
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow, Russian Federation
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russian Federation
| | - D Yu Pushkar
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
- City Clinical Hospital n.a. S.I. Spasokukotsky, Moscow, Russian Federation
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russian Federation
| |
Collapse
|
9
|
Pushkar DY, Kupriyanov YA, Gamidov SI, Teteneva AV, Spivak LG, Shormanov IS, Novikov AI, Al-Shukri SK, Bogdan EN, Shchukin VL, Boriskin AG. [Assessment of the safety and efficacy of medicinal product PPR-001 based on regulatory polypeptides of the testes]. Urologiia 2021:100-109. [PMID: 34967170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVE Evaluation of the effectiveness and safety of the drug PPR-001 (lyophilizate) in comparison with placebo in men with impaired spermatogenesis. MATERIALS AND METHODS This study was a randomized, double-blind, placebo-controlled, prospective, multicenter, parallel-group research. RESULTS It was found that the drug has clinical efficacy and a positive effect on the concentration of spermatozoa in the ejaculate, the percentage of progressively mobile forms and the number of morphologically normal forms of spermatozoa was increased in the group of PPR-001. The primary end point was defined as a proportion of patients who had a therapeutic response (TO) at Visit 3. TO meant at least 20% increase in the concentration and/or progressive motility of spermatozoa compared to the baseline level. The hypothesis of Superiority of PPR-001 over placebo based on primary end point was confirmed (the limit of Superiority was more than 27%). In total, AEs were identified in 65 patients out of 100 (34 patients in the PPR-001 group and 31 patients in the placebo group). When assessing the number of patients who had AEs, there were no statistically significant differences between the groups. All identified AEs were of mild severity; during the study. No negative dynamics was found according to the results of the assessment of vital functions, biochemical and clinical blood tests, clinical urinalysis, ECG indicators. CONCLUSION The study demonstrated the superiority of PPR-001 over placebo in terms of increasing concentration and motility of spermatozoa in the ejaculate. A significant increase in the number of morphologically normal forms of spermatozoa in the PPR-001 group was also revealed.
Collapse
Affiliation(s)
- D Yu Pushkar
- FSBEI of Higher Education Moscow State University of Medicine and Dentistry named after A.I. Evdokimov" of the Ministry of Health of the Russian Federation, Moscow, Russian
| | - Y A Kupriyanov
- FSBEI of Higher Education Moscow State University of Medicine and Dentistry named after A.I. Evdokimov" of the Ministry of Health of the Russian Federation, Moscow, Russian
| | - S I Gamidov
- FSBI National Medical Research Center of Obstetrics, Gynecology and Perinatology named after ac. V.I. Kulakov of the Ministry of Health of the Russian Federation, Moscow, Russian
| | - A V Teteneva
- OGBUZ "Medical and sanitary unit No. 2", Tomsk, Russian
| | - L G Spivak
- LLC "Family polyclinic No. 4", Moscow region, Korolev, Russian
| | - I S Shormanov
- FSBEI of Higher Education "Yaroslavl State University of Medicine" of the Ministry of Health of the Russian Federation, Yaroslavl, Russian
| | - A I Novikov
- LLC "New clinic" ABIA", St. Petersburg, Russian
| | | | - E N Bogdan
- LLC "Aurora Medi", St. Petersburg, Russian
| | - V L Shchukin
- LLC "Research Center Eco-safety", St. Petersburg, Russian
| | | |
Collapse
|
10
|
Akhvlediani ND, Reva IA, Chernushenko AS, Pushkar DY. [Andrological aspects of new coronavirus infection Covid-19]. Urologiia 2021:130-135. [PMID: 34967175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
COVID-19 is a new highly contagious infectious disease caused by the SARS-CoV-2. The World Health Organization (WHO) on March 11, 2020, has declared the novel coronavirus (COVID-19) outbreak a global pandemic. More attention is currently paid to the fact that men are more at risk for worse outcomes. In addition, SARS-CoV-2 can infect the testes, potentially affecting testosterone production, as well as having a negative influence on the reproductive potential. Our aim was to review the current concepts of the possible influence of testosterone levels on the pathogenesis of COVID-19 in men and to present the available data on the impact of COVID-19 on the structure and function of the testis. Based on the analysis of 72 articles using the MEDLINE database (PubMed), it can be concluded that testosterone is involved in the co-regulation of the synthesis of angiotensin-converting enzyme-2 and transmembrane serine protease-2, facilitating the penetration of SARS-CoV-2 into target cells and promoting easier infection in men. On the other hand, low testosterone levels increase the risk of cardiopulmonary complications. Hypogonadism appears to be an important unfavorable prognostic factor for the disease. Orchitis is a reported complication of COVID-19. Damage to testicular tissue is possible due to direct invasion by a virus, a secondary autoimmune reaction, hyperthermia and thrombosis of testicular microvessels. Prophylaxis of possible vertical and sexual transmission of infection is recommended. Despite the available data, further studies are required to assess the definite role of androgens in the course of infection and the influence of SARS-CoV-2 on male reproductive potential.
Collapse
Affiliation(s)
- N D Akhvlediani
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - I A Reva
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A S Chernushenko
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
11
|
Akhvlediani ND, Reva IA, Chernushenko AS, Pushkar DY. [Sperm retrieval techniques in patients with non-obstructive azoospermia]. Urologiia 2021:106-113. [PMID: 34486283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Patients with non-obstructive azoospermia (NOA), which accounts for up to 10-15% of all cases of male infertility, until recently could only become parents using donor sperm or through adoption. Modern technical capabilities of sperm extraction in combination with the use of assisted reproductive technologies, make it possible to effectively overcome infertility in this group of patients. A number of highly effective techniques have been proposed for spermatozoa retrieval. However, surgical intervention is associated with certain risks, and therefore, the choice of the optimal treatment method is under discussion. A total of 52 articles were analyzed using the MEDLINE database (PubMed) to form an overview of the current principles of examination and preparation of a patient with NOA for the surgical sperm retrieval. This review is dedicated to the role of diagnostic testicular biopsy. In addition, a comparative information on the efficacy and safety of percutaneous, fine-needle aspiration, open multifocal and microdissection (micro-TESE) testicular biopsies is presented. Of the currently available sperm retrieval techniques in the urologic armamentarium, micro-TESE seems to be both the most effective and the safest. Micro-TESE can be a cumbersome procedure, however, it provides successful treatment in situations previously associated with zero chance of pregnancy.
Collapse
Affiliation(s)
- N D Akhvlediani
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - I A Reva
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A S Chernushenko
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
12
|
Tikhonova LV, Kasyan GR, Stroganov AB, Mukhtarov ST, Sheripbaev RB, Dyakov VV, Pushkar DY. [Diagnostic nomograms for the treatment of urogenital fistula]. Urologiia 2021:13-20. [PMID: 33818929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
AIM Studies on non-obstetric urogenital fistula provide limited information on predictive factors. The aim of our study was to specify and to analyze the predictors for long-term anatomical and functional results in women with non-obstetric urogenital fistula. MATERIALS AND METHODS A cross-section study of surgical repair for non-obstetric urogenital fistula repairs was carried out. From 2012 to 2018, a total of 446 patients with urogenital fistulas were treated in two tertiary centers. Patients with vesicovaginal and urethrovaginal fistulas with at least 12 months of follow-up were identified and contacted by phone and/or examined in the clinic. Anatomical outcome was assessed by resolution of symptoms and/or results of clinical examination. Urinary distress inventory (UDI-6) was used for the measurement of functional outcomes. The nomogram is based on a multiple regression equation, the solution of which is performed using a computer. The nomogram is presented as a set of scales, each of which corresponds to a certain variable. The baseline parameter is assigned certain points, depending on its value, then the sum of all parameters is calculated. As a result, it is possible to determine the risk using a couple or three scales. RESULTS Overall, 169 patients were studied (mean age of 49.2, mean follow-up of 34 months). The most common cause of fistulas included hysterectomy (69.4%), followed by pelvic radiotherapy (18.9%). Only 64% of cases were primary fistula. Closure rate was 90.7% (98/108). Anatomical success depended on the surgical approach. For transvesical procedure, success rate was 89.4% (42/47), compared to 84% (89/106) and 87.5% (14/16), respectively for transvaginal and transabdominal success rate. According to Clavien-Dindo, complications were grade 1 (11.8%) and grade 2 (4.7%). As UDI-6 showed, the most common symptoms were frequency (62%), urgency (50%), incontinence (73%), pain (55%) and voiding symptoms (27%). Fistula size > 3.0 cm, pelvic radiation, and previous vaginal surgeries were associated with a higher risk of failure or more severe lower urinary tract symptoms. A high number of re-do cases and complex fistulas could be a limitation of this study. Factors for successful non-obstetric urogenital fistula closure were fistula size less than 3.0 cm, absence of pelvic radiation, and previous vaginal surgeries. CONCLUSION According to our results, only fistula size > 3 cm, previous vaginal procedures and pelvis irradiation were unfavorable predictors for anatomic success of fistula repair. In addition, our results allow to determine the predictors for successful repair and risk of recurrence lower urinary tract symptoms postoperatively.
Collapse
Affiliation(s)
- L V Tikhonova
- Department of Urology of A. I. Evdokimov Moscow State University of Medicine and Dentistry
- AO European Medical Center, urologic clinic, Moscow, Russia
| | - G R Kasyan
- Department of Urology of A. I. Evdokimov Moscow State University of Medicine and Dentistry
| | - A B Stroganov
- Department of Urology of A. I. Evdokimov Moscow State University of Medicine and Dentistry
| | - S T Mukhtarov
- Republican Specialized Center of Scientific and Practical Urology, Tashkent, Uzbekistan
| | - R B Sheripbaev
- Republican Specialized Center of Scientific and Practical Urology, Tashkent, Uzbekistan
| | - V V Dyakov
- Department of Urology of A. I. Evdokimov Moscow State University of Medicine and Dentistry
| | - D Yu Pushkar
- Department of Urology of A. I. Evdokimov Moscow State University of Medicine and Dentistry
| |
Collapse
|
13
|
Tikhonova LV, Kasyan GR, Pushkar DY, Grigoriev NA. [Systematic review of current russian-language literature on urogenital fistulas in women]. Urologiia 2020:137-141. [PMID: 33377693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Urogenital fistulas in women are an urgent problem in modern urology, gynecology and surgery. Several decades earlier, iatrogenic damage was the main reason for their development. The aim of this review was to analyze the etiology, characteristics and results of treatment of fistulas in women in Russia and the CIS countries. A systematic analysis of the articles in the PubMed and eLibrary databases dedicated to etiology, treatment technique and postoperative results of treatment of urogenital fistulas in women was carried out. The results were compared with European data. A total of 16 articles were selected over a 20-year period that met the inclusion criteria. Iatrogenic injury resulted in the fistula formation in 40.54% (373/920) of cases. The majority of fistulas were caused by radiation therapy (58.91%, 542/920). According to the results, 84.02% (773/920) of fistulas were successfully healed. Cure rate of patients with post-radiation fistulas was 75.83% (411/542). Comparison of surgical techniques was difficult, since in most cases the preference of the surgeon was main determinant factor.
Collapse
Affiliation(s)
- L V Tikhonova
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- AO European Medical Center, Moscow, Russia
| | - G R Kasyan
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
| | | |
Collapse
|
14
|
Kovylina MV, Astakhova OI, Zayratyants OV, Prilepskaya EA, Reshetov LV, Kolontarev KB, Pushkar DY. [Acute kidney injury in COVID-19: clinical and morphological comparisons based on autopsy data]. Urologiia 2020:5-10. [PMID: 33377671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
UNLABELLED Severe Acute Respiratory Syndrome (SARS-CoV-2) has spread rapidly throughout the world, causing high morbidity and mortality. Analysis of clinical and autopsy data may allow to understand this disease. The results of pulmonary and renal autopsies in 37 deceased patients from COVID-19 are presented. MATERIALS AND METHODS An autopsy was performed in Moscow in 37 deceased patients aged from 28 to 94 years. The microscopic features of the lungs and kidneys were examined using hematoxylin and eosin staining. RESULTS Important findings include diffuse alveolar injury, pulmonary thrombosis and microangiopathy, as well as acute kidney injury in all cases, varying in severity. CONCLUSIONS We report the presence of acute kidney injury in all cases, which requires correction of renal function in patients with SARS-CoV-2, with control of serum creatinine levels, urine volume, proteinuria and hematuria.
Collapse
Affiliation(s)
- M V Kovylina
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - O I Astakhova
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| | - O V Zayratyants
- Department of Pathologic Anatomy of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - E A Prilepskaya
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - L V Reshetov
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - K B Kolontarev
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
15
|
Vasilyev AO, Sazonova NA, Shiryaev AA, Kim YA, Zaitsev AV, Gabdullin AF, Melnikov VD, Revazova ZV, Pushkar DY. [ORGANIZATION OF MEDICAL CARE FOR ELDERLY PATIENTS UNDER THE CONDITIONS OF THE COVID-19 PANDEMIC]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2020; 28:1081-1086. [PMID: 33219762 DOI: 10.32687/0869-866x-2020-28-s2-1081-1086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Accepted: 07/29/2020] [Indexed: 11/06/2022]
Abstract
The first report of the new coronavirus infection (COVID-19) appeared at the end of December 2019 and in March,2020 the World Health Organization announced COVID-19 a pandemic. The steady number of newly detected cases increase predetermined the modernization of the global healthcare system, shifting the paradigm of fighting with the COVID-19 pandemic towards maximum resource conservation. The change in the medical care provision for infectious patient's approach led first to a gradual decrease, and then to a complete cessation of planned surgical treatment, outpatient examinations, as well as observation of high-risk patients, which primarily include elderly patients. As a result of this, the key objective of this systematic review was to analyze sources of existing practice of providing urological care to patients of the older age group in the context of the COVID-19 pandemic. In accordance with the search for the keywords, the study reflects world and its own experience of MSMSU Urology Department in the treatment of age-related patients in the current epidemiological situation. The analysis showed that infectious complications from the urinary system take a leading position among the common complications inherent in elderly patients with COVID-19. The development of catheter-associated infection, the occurrence of antibiotic-resistant forms of bacteria, asymptomatic bacteriuria are only a small part of the problems clinicians have to face in newly profiled departments.
Collapse
Affiliation(s)
- A O Vasilyev
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation.,SBHI «City Clinical Hospital named after S. I. Spasokukotsky» MHD, 127206, Moscow, Russian Federation.,State Budgetary Institution "Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department", 115088 Moscow, Russian Federation
| | - N A Sazonova
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation,
| | - A A Shiryaev
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation.,SBHI «City Clinical Hospital named after S. I. Spasokukotsky» MHD, 127206, Moscow, Russian Federation
| | - Yu A Kim
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation.,SBHI «City Clinical Hospital named after S. I. Spasokukotsky» MHD, 127206, Moscow, Russian Federation
| | - A V Zaitsev
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation.,SBHI «City Clinical Hospital named after S. I. Spasokukotsky» MHD, 127206, Moscow, Russian Federation
| | - A F Gabdullin
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation
| | - V D Melnikov
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation
| | - Z V Revazova
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation.,SBHI «City Clinical Hospital named after S. I. Spasokukotsky» MHD, 127206, Moscow, Russian Federation
| | - D Yu Pushkar
- A. I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russian Federation.,SBHI «City Clinical Hospital named after S. I. Spasokukotsky» MHD, 127206, Moscow, Russian Federation
| |
Collapse
|
16
|
Shiryaev AA, Govorov AV, Vasilyev AO, Pushkar DY. [Alpha1-adrenergic blockers therapy and sexual function]. Urologiia 2020:82-86. [PMID: 33185353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
An increase in life expectancy and the number of older and elderly men, an improvement in the quality of medical care and socio-economic factors in most countries contributed to an increase in the number of patients with benign prostatic hyperplasia (BPH). Currently, improvement of the quality of life is the mainstay of strategy for managing patients with BPH, as well as prevention of complications and the need for surgery. In this regard, the pharmacotherapy with 1-adrenergic blockers (1-AB) is widely used as an effective method for improving lower urinary tract symptoms and reducing the risk of BPH progression. Given that the quality of life is becoming increasingly important in evaluating the efficiency of BPH treatment, including therapy in elderly patients, it is necessary to take into account its effect on sexual function, when choosing a particular drug. The use of 1-AB can be accompanied by side effects manifested by various sexual disorders. Alfuzosin does not adversely affect sexual function in men with BPH, may improve erectile and ejaculatory function and should be considered as the drug of choice, especially in sexually active men and patients who already suffer from worsening ejaculatory function while using another 1-AB.
Collapse
Affiliation(s)
- A A Shiryaev
- Department of Urology of the Moscow State Medical-Dental University named after A.I. Evdokimov, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| | - A V Govorov
- Department of Urology of the Moscow State Medical-Dental University named after A.I. Evdokimov, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| | - A O Vasilyev
- Department of Urology of the Moscow State Medical-Dental University named after A.I. Evdokimov, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
- Research Institute for Healthcare Organization and Medical Management, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of the Moscow State Medical-Dental University named after A.I. Evdokimov, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department, Moscow, Russia
| |
Collapse
|
17
|
Akhvlediani ND, Reva IA, Chernushenko AS, Bernikov AN, Pushkar DY. [A role of varicocele in the development of male infertility and methods of surgical treatment]. Urologiia 2020:111-118. [PMID: 32897024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Varicocele is the most common and treatable cause of male infertility. Therefore, surgical treatment of varicocele should be recommended for motivated patients and infertile couples who do not have other identified causes of infertility. Varicocelectomy has been proved to improve sperm parameters and improve chances of successful conception in most patients. However, surgical treatment is associated with certain risks, and therefore, the choice of the optimal treatment is under discussion. A total of 78 articles using a search in MEDLINE database (PubMed) were found and included in the review, dedicated to current concepts of functional anatomy of testicular arteries and veins. The current recommendations of professional communities regarding the selection of patients for varicocelectomy are described. The efficiency and safety of various surgical procedures for varicocele is analyzed. This review suggests high inconsistences in the literature. The available information on the indications for surgical treatment, as well as comparative data on the efficiency and safety of the inguinal, laparoscopic and microsurgical sub-inguinal approaches are presented. When urologist faces with a diagnosis of varicocele, individual approach should be applied, with a discussion of both benefits and possible complications of surgical treatment. Of the many existing techniques, microsurgical ligation of dilated veins is the most preferred.
Collapse
Affiliation(s)
- N D Akhvlediani
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - I A Reva
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A S Chernushenko
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A N Bernikov
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- University Clinic Kuskovo of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
18
|
Krasavtseva YV, Kiseleva MG, Kasyan GR, Pushkar DY. [Assessment of the psychological status of urologists during the COVID-19 pandemic]. Urologiia 2020:5-9. [PMID: 32597578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
UNLABELLED The aim of this study was to analyze the symptoms of depression, anxiety, and stress in urologists during the COVID-19 pandemic. MATERIALS AND METHODS 90 urologists aged 25 to 60 years (M=37.27, S.D.=9.53), 93% of them were men, participated in the online survey. They answered questions about their attitude to their job as doctors and the impact of COVID-19. They filled out the Depression, Anxiety and Stress Scales (DASS-21), the Ten Item Personality Inventory (TIPI) and answered questions assessing their sense of control. RESULTS The greatest concern among urologists is the risk of getting infected with COVID-19 (for 30% of the doctors). 43% of urologists state that their profession interesting. A positive attitude to work, as well as the Big Five traits (Conscientiousness, Emotional Stability and Agreeableness) are associated with lower levels of depression, anxiety, stress and lack of control. Working with COVID-19 patients reduces stress and increases the sense of control. Age and high levels of Emotional Stability predicted lower levels of anxiety, depression and stress. DISCUSSION Working with COVID-19 patients allows doctors to feel more control over what is happening. A sense of control, in turn, and a positive attitude towards work are associated with a lower levels of depression, anxiety and stresssymptoms. CONCLUSION The results of this study can be used in selection of therapeutic targets for psychotherapy, administered to doctors; in prevention of symptoms of anxiety, stress and depression among doctors; and in professional selection of doctors for working in crisis situations.
Collapse
Affiliation(s)
- Yu V Krasavtseva
- FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - M G Kiseleva
- FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - G R Kasyan
- FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - D Yu Pushkar
- FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| |
Collapse
|
19
|
Vasil'ev AO, Zaycev AV, Shiryaev AA, Prilepskaya EA, Kim YA, Kalinina NA, Pushkar DY. [Immune response to lower urinary tract infections]. Urologiia 2020:118-121. [PMID: 32351074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Urinary tract infections are one of the most common and widespread infectious diseases. A certain role in etiopathogenesis may play genetic predisposition, as well as a decrease in antiadhesive properties and an increase in urothelium permeability due to incompetence of bladder glycosaminoglycan layer. The prevalence of infectious diseases increases significantly with age, as well as in patients with chronic diseases. The introduction of modern biotechnology has allowed clinicians to greatly expand therapeutic armamentarium, while having a number of advantages, including minimal frequency of complications and adverse events, the possibility for long-term use, accessibility, and etc. Priority research areas include the study of toll-like receptors, which are transmembrane proteins that provide pathogen recognition and activate the immune response. The role of these receptors in the development of the immune response to urinary tract infections was evaluated in our study, which allows to predict the course of the disease and to increase treatment efficiency.
Collapse
Affiliation(s)
- A O Vasil'ev
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - A V Zaycev
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - A A Shiryaev
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - E A Prilepskaya
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - Yu A Kim
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - N A Kalinina
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
| |
Collapse
|
20
|
Gamidov SI, Pushkar DY, Vasiliev AO, Govorov AV, Dusmukhamedov RN, Shneiderman MG, Shatylko TV, Gasanov NG. [Evaluation of the clinical efficacy of urethroplasty after failed hypospadias repair]. Urologiia 2020:5-11. [PMID: 32190997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
BACKGROUND Evaluation of surgical treatment of hypospadias is one of the most controversial problem in urology, considering a lack of continuity in the management of these patients between pediatric andrologists and general urologists. Patients who undergone to multiple hypospadias repairs remain one of the most difficult categories for reconstructive urethral surgery and urology in general. MATERIALS AND METHODS The treatment results of 112 adult patients who had complications of previously performed hypospadias repairs were evaluated. The results of repeated procedures were compared in patients, in whom modified balloon urethral catheter (group 1; n=50) or standard Foley catheter (group 2; n=62) was used, respectively. RESULTS Most patients after surgery assessed the appearance of the penis as "good" (92% in group 1, 77.4% in group 2). In group 1, satisfactory results was seen in 8% of cases and there were no unsatisfactory results, while in group 2, where standard Foley catheter was used, these values were 19.4% and 3.2%, respectively. In group 1, complication rate was lower than in group 2 (10% versus 41.9%; p<0.05). In group 1, there was a significantly higher proportion of patients with a Qmax score of more or equal 18 ml/s (90% versus 74.2%; p<0.05). CONCLUSIONS Repeated procedures in adult men with late complications of surgical treatment of hypospadias are quite effective, although they are accompanied by a rather high complications rate. The use of a new model of the urethral catheter with dilating cuff and an irrigation canal allows to improve treatment results in this category of patients.
Collapse
Affiliation(s)
- S I Gamidov
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| | - D Yu Pushkar
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| | - A O Vasiliev
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| | - A V Govorov
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| | - R N Dusmukhamedov
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| | - M G Shneiderman
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| | - T V Shatylko
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| | - N G Gasanov
- Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University
- Department of Additional Technologies for treatment of infertility named after professor B.V. Leonov of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Moscow, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of Russia, Moscow, Russia
- Department of Urology and Andrology in N.I. Pirogov RNRMU, Moscow, Russia
| |
Collapse
|
21
|
Akhvlediani ND, Chernushenko AS, Pushkar DY, Bernikov AN, Reva IA. [Surgical approaches for implanting of three-piece penile prosthetics]. Urologiia 2019:166-169. [PMID: 32003189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Implantation of three-piece penile prosthesis is a gold standard in patients with severe erectile dysfunction. Currently, three surgical approach (scrotal, suprapubic and subcoronal) are used for prosthetic implantation. A method of implantation for three-piece penile prosthesis is still under discussion. The literature dedicated to an influence of surgical approach on the results of implantation for three-piece penile prosthesis in patients with severe erectile dysfunction is reviewed. The advantages and drawbacks of each technique are mentioned.
Collapse
Affiliation(s)
- N D Akhvlediani
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A S Chernushenko
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A N Bernikov
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - I A Reva
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
22
|
Shiryaev AA, Vasilyev AO, Zaitsev AV, Prilepskaya EA, Sazonova NA, Grigoryan IE, Kim YA, Pushkar DY. [Prospects of using bacteriophages in urological practice]. Urologiia 2019:131-136. [PMID: 32003183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
In modern clinical practice, antimicrobial resistance creates a significant problem for the effective metaphylaxis of various infectious and inflammatory diseases of the urinary system. Annually, researchers note an increasing number of mutations in the genomes of bacteria that cause infectious diseases, which leads to the appearance of more aggressive strains. The inefficiency of antibiotic therapy requires to a search for alternative methods for treatment and prevention of infectious diseases. use of viruses that infect bacteria (bacteriophages) represent one of such methods. A literature review of recent publications indicates that phage therapy has been gained significant increase. The general aspects of phage therapy, mechanism of action, as well as the existing possibilities and limitations of phage therapy in treatment and prevention of infectious diseases of the urinary system are highlighted in this article.
Collapse
Affiliation(s)
- A A Shiryaev
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| | - A O Vasilyev
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| | - A V Zaitsev
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| | - E A Prilepskaya
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| | - N A Sazonova
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| | - I E Grigoryan
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| | - Yu A Kim
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
| |
Collapse
|
23
|
Pushkar DY, Govorov AV, Vasilyev AO, Kolontarev KB, Prilepskaya EA, Kovylina MV, Sadchenko AV, Sidorenkov AV. [Moscow program of early detection and treatment of prostate cancer]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2019; 27:677-686. [PMID: 31747161 DOI: 10.32687/0869-866x-2019-27-si1-677-686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/10/2019] [Accepted: 06/04/2019] [Indexed: 11/06/2022]
Abstract
The aim of this study is to improve the results of detection and treatment of patients with prostate cancer (PCa) in the Moscow. For this purpose, we performed our own clinical diagnostic, epidemiological, autopsy, experimental and comparative studies that emphasize the relevance of the stated subject in the study of the diagnosis and treatment of patients with PCa. Urology Department of A. I. Evdokimov Moscow State University of Medicine and Dentistry was at the forefront of the Men's Health program in Moscow and in early 2003 it was the first to have an office for early diagnosis of prostate diseases, as part of the Program. Over 20,000 patients were screened for PCa. For the first time in Russia, methods for the early detection of PCa were investigated on a cohort of Russian men using PCA3 and the Prostate Health Index. The role and significance of prostate saturation biopsy was examined. The investigation of aspects of the morphological assessment of prostate diseases formed the basis for the development of an electronic atlas of PCa images. A series of studies on various prostate visualization methods, including Histoscanning system and MRI, have been performed. A new minimally invasive method for the treatment of prostate cancer has been introduced - a robot-assisted radical prostatectomy and cryoablation. The concept of surgical treatment of localized forms of PCa has been developed and the factors predicting the success of treatment have been determined. This study is reflected in numerous publications both in Russia and abroad, in monographs and dissertations.
Collapse
Affiliation(s)
- D Yu Pushkar
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia.,A. I. Evdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia
| | - A V Govorov
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia.,A. I. Evdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia
| | - A O Vasilyev
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia, .,A. I. Evdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia
| | - K B Kolontarev
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia.,A. I. Evdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia
| | - E A Prilepskaya
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia.,A. I. Evdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia
| | - M V Kovylina
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia.,A. I. Evdokimov Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia
| | - A V Sadchenko
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia
| | - A V Sidorenkov
- S. I. Spasokokukotsky City Clinical Hospital, 127206, Moscow, Russia
| |
Collapse
|
24
|
Koshmelev AA, Baranova EO, Trebushenkov AY, Dudarev VA, Zhivov AV, Pushkar DY. [Partial segmental thrombosis of upper part of the corpus cavernosum]. Urologiia 2019:119-123. [PMID: 31808645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
A clinical observation of the distal segmental thrombosis of the left corpus cavernosum is presented in the article. Efficient treatment was based on the results of contrast MRI, and timely application of long-term doses of antithrombotic drugs was done. It is allowed to avoid short-term formation of such a complication as cavernous fibrosis.
Collapse
Affiliation(s)
- A A Koshmelev
- Medical Center Semeynaya, Moscow, Russia
- European Medical Center, Moscow, Russia
- Chita State Medical Academy, Chita, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - E O Baranova
- Medical Center Semeynaya, Moscow, Russia
- European Medical Center, Moscow, Russia
- Chita State Medical Academy, Chita, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A Yu Trebushenkov
- Medical Center Semeynaya, Moscow, Russia
- European Medical Center, Moscow, Russia
- Chita State Medical Academy, Chita, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - V A Dudarev
- Medical Center Semeynaya, Moscow, Russia
- European Medical Center, Moscow, Russia
- Chita State Medical Academy, Chita, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A V Zhivov
- Medical Center Semeynaya, Moscow, Russia
- European Medical Center, Moscow, Russia
- Chita State Medical Academy, Chita, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Medical Center Semeynaya, Moscow, Russia
- European Medical Center, Moscow, Russia
- Chita State Medical Academy, Chita, Russia
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
25
|
Zhivov AV, Tedeev RL, Koshmelev AA, Karpovich AV, Yudovskyi SO, Pushkar DY. [Results of treatment and risk factors for recurrence of iatrogenic urethral strictures in men]. Urologiia 2019:7-13. [PMID: 31808625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
AIM Iatrogenic etiologies continue playing an increasing role in the formation of urethral strictures (US) in the industrially developed countries. Our aim was to study specific iatrogenic causative factors in the etiology of US, treatment efficacy and risk factors of their recurrence. MATERIALS AND METHODS A total of 230 men with iatrogenic urethral strictures operated between 2008 and 2017 were included into the study group. Median age was 58.7+/-15.3 years. Inclusion criteria were presence of iatrogenic etiologic factor, open reconstruction or visual internal urethrotomy as a treatment, absence of other etiologic factors. Patients were investigated using the standard protocol. Postoperative follow up time ranged from 14 to 102 months, median 43 months. RESULTS Average stricture length was 5,8+/-4,7 cm (1-24 cm). Primary stricture was diagnosed in 107 (46.5%) patients, while 123 (53.5%) patients with recurrent stricture were treated. Localization of urethral stricture was as following: anterior urethra (62.2%), posterior urethra (12.6%) and combined anterior/posterior strictures (25.2%). Endoscopic surgical procedures were the major cause of iatrogenic US followed by urethral catheterizations, hypospadias repair and surgical/radiation therapy of prostate cancer. The whole efficacy of surgical treatment in iatrogenic US was 84,8%. Treatment success after anastomotic urethroplasties was higher than after augmented or substitution surgical procedures. Independent risk factors for US recurrence were: 1) augmentation or substitution urethroplasty; 2) history of hypospadias repair; 3) stricture length more or equal 5,5 cm. CONCLUSION Establishment of the particular etiologic factors may help to prevent iatrogenic US. Current methods of the US surgical management are highly effective but anastomotic urethroplasties should be preferred over augmentation and substitution techniques when possible.
Collapse
Affiliation(s)
- A V Zhivov
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
| | - R L Tedeev
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
| | - A A Koshmelev
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
| | - A V Karpovich
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
| | - S O Yudovskyi
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
| |
Collapse
|
26
|
Akhvlediani ND, Reva IA, Bernikov AN, Chernushenko AS, Pushkar DY. [Penile prosthesis implantation through subcoronal approach in patients with total cavernous fibrosis]. Urologiia 2019:96-100. [PMID: 31535813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Penile prosthesis implantation is a treatment choice in patients with erectile dysfunction (ED) accompanied by cavernous fibrosis. Methods for creation of space for penile cylinders during prosthesis implantation in patents with total cavernous fibrosis are still under discussion, considering high risk of complications and decrease in penile size. In the presented clinical case, a new surgical technique for performing a three-piece penile prosthesis implantation through subcoronal approach in patient with ED, complicated by total cavernous fibrosis, is described. This clinical case represents our first experience of excavation excision of scar tissue in cavernous bodies through an innovative subcoronoral approach. As a result of performing of excavation excision of scar tissue in cavernous bodies, capacious spaces were created which allowed to use a three-piece prosthesis with a standard cylinder diameter. It ensured good long-term functional and cosmetic results. The first experience of excavation excision of fibrotic cavernous bodies during inflatable penile prosthesis implantation through subcoronal approach suggests its potential efficacy and safety in patients with ED and total cavernous fibrosis.
Collapse
Affiliation(s)
- N D Akhvlediani
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - I A Reva
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A N Bernikov
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A S Chernushenko
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
27
|
Okishev AV, Govorov AV, Vasilyev AO, Bormotin AV, Pushkar DY. [Fusion biopsy of the prostate]. Urologiia 2019:142-148. [PMID: 31356028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
AIM to compare the prostate cancer (PCa) detection rate, accuracy and safety of prostate image-guided fusion biopsy methods (cognitive fusion, software-fusion and HistoScanning-guided biopsy) on the basis of published studies in patients from 48 to 75 years with suspected prostate cancer during primary or repeat biopsy. To identify the limitations of these methods and improve the efficiency of fusion biopsy of the prostate in a further clinical trial. MATERIALS AND METHODS search was carried out in the PubMed, Medline, Web of Science and eLibrary databases using following requests: (prostate cancer OR prostate adenocarcinoma) AND (MRI or magnetic resonance) AND (targeted biopsy); (prostate cancer OR prostate adenocarcinoma) AND (PHS OR Histoscanning) AND (targeted biopsy) and (prostate cancer OR prostate adenocarcinoma) AND (MRI or magnetic resonance) AND (targeted biopsy) AND (cognitive registration), targeted prostate biopsy, prostate histoscanning, histoscanning, cognitive prostate biopsy. RESULTS a total of 672 publications were found, of which 25 original scientific papers were included in the analysis (n=4634). According to the results, PCa detection rate in patients with an average age of 62.5 years. (48-75) and an average PSA of 6.3 ng/ml (4.1-10.8), who underwent cognitive fusion biopsy under MRI control (MR-fusion) was 32.5%, compared to 30% and 35% for histoscanning in combination with a systematic biopsy and combination of methods (MR-fusion biopsy and histoscanning-guided biopsy), respectively. The accuracy of cognitive MR-fusion biopsy was 49.8% (20.8%-82%), the accuracy of the software MR-fusion biopsy was 52.5% (26.5%-69.7%), the accuracy of histoscanning-guided targeted biopsy was 46.8% (26%-75.8%). The highest values were observed in the patients undergoing primary biopsy (75.8%). DISCUSSION Currently, imaging methods allow us to change the approach to the diagnosis of PCa by improving the efficiency of prostate biopsy, the only formal method for verifying PCa. A common method for PCa diagnosis in 2018 is a systematic prostate biopsy. However, due to the its drawbacks, fusion biopsy under control of MRI or ultrasound has being introduced into clinical practice with superior results. So far, there is a lack of sufficient scientific data to select a specific technique of the fusion biopsy of the prostate. According to the analysis, it was concluded that the incidence of complications didnt increase when performing targeted biopsy in addition to the systematic protocol. CONCLUSION The efficiency of cognitive MR-fusion biopsy is comparable to software MR-fusion biopsy. Histoscanning-guided biopsy has lower diagnostic value than MR-guided target biopsy using software. The lack of solid conclusions in favor of a particular prostate fusion biopsy technique stresses on the relevance of further research on this topic.
Collapse
Affiliation(s)
- A V Okishev
- Department of Urology of MSMSU named after A.I. Evdokimov, Moscow, Russia
| | - A V Govorov
- Department of Urology of MSMSU named after A.I. Evdokimov, Moscow, Russia
| | - A O Vasilyev
- Department of Urology of MSMSU named after A.I. Evdokimov, Moscow, Russia
| | - A V Bormotin
- Department of Urology of MSMSU named after A.I. Evdokimov, Moscow, Russia
| | - D Y Pushkar
- Department of Urology of MSMSU named after A.I. Evdokimov, Moscow, Russia
| |
Collapse
|
28
|
Kupriyanov YA, Rasner PI, Rokhlikov IM, Akrikidi AA, Soloviev VV, Markov AA, Nozdrin EV, Logvinov LA, Vasilevskiy RP, Skrupskiy KS, Pushkar DY, Putilovskiy MA, Epstein OI. [The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia]. Urologiia 2019:36-42. [PMID: 31356011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
INTRODUCTION Benign prostatic hyperplasia (BPH) is one of the most common diseases in men over 50 years. The prevalence of the BPH increases with age, and pathologic features of BPH are found in about 90% of men over 80 years. AIM The aim of the study was to study the efficacy and safety of Afalaza for the treatment of lower urinary tract symptoms (LUTS) in treatment-nave patients with BPH. MATERIALS AND METHODS A multicenter study of using Afalaza for the treatment of LUTS in treatment-nave patients with BPH was carried out in 9 urological centers in Moscow. A total of 80 treatment-nave patients with BPH were enrolled. The improvement in the total score of IPSS, IIEF-5 and QoL after 30 weeks of therapy was evaluated as well as changes in prostate volume and maximum urinary flow rate (Qmax). RESULTS After 30 weeks of therapy, there was a significant decrease in the total IPSS score. A decrease in the total IPSS score by 5.5 points (+37.9%) from 14.5+/-4.0 at the baseline to 9.0+/-4.1 at the visit 9 was seen. The QoL decreased by 1.8 (-38.3%) points from 4.7+/-1.0 at the baseline. The Qmax also changed from 12.7+/-4.6 to 16.4+/-5.7 (+28.3%) after 30 weeks of therapy. At the visit 9, the total IIEF5 score increased by 3.4+/-4.4 (+19.9%) from 17.1+/-4.3 at the baseline. In addition, prostate volume decreased from 42.7+/-11.1 at baseline to 41.0+/-9.8 cc post-treatment (-5.15%). A reduction of post-void residual urine volume from 26.0+/-25.3 at baseline to 17.7+/-24.2 (-31.9%) post-treatment was also shown. CONCLUSION The results of a multicenter study demonstrate the efficacy of Afalaza for treatment of treatment-nave patients with LUTS/BPH. Afalaza reduces prostate volume and improves an erectile function.
Collapse
Affiliation(s)
- Yu A Kupriyanov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - P I Rasner
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - I M Rokhlikov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - A A Akrikidi
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - V V Soloviev
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - A A Markov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - E V Nozdrin
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - L A Logvinov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - R P Vasilevskiy
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - K S Skrupskiy
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - D Yu Pushkar
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - M A Putilovskiy
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| | - O I Epstein
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- Municipal clinical hospital named after S.I. Spasokukotskiy, Moscow, Russia
- NPF Materia Medica Holding LTD, Moscow, Russia
- Research Institute of General Pathology and Pathophysiology, Moscow, Russia
- GBUZ CP 68 of Moscow Health Department
- GBUZ CP 29 of Moscow Health Department
- GBUZ CP 170 of Moscow Health Department
- GBUZ CP 107 of Moscow Health Department
- GBUZ CP 201 of Moscow Health Department
- GBUZ CP 69 of Moscow Health Department
- GBUZ CP 134 of Moscow Health Department
| |
Collapse
|
29
|
Akhvlediani ND, Pushkar DY, Bernikov AN, Chernushenko AS, Reva IA. [Penile prosthesis implantation through subcoronal approach with graft-free corporoplasty in patients with Peyronie disease with concomitant erectile dysfunction]. Urologiia 2019:124-127. [PMID: 31356025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Penile prosthesis implantation is a treatment choice in patients with erectile dysfunction (ED) and concomitant penile curvature due to Peyronie disease. Methods for correction of penile deformity during prosthesis implantation are still under discussion, considering variable efficiency and higher risk of complications. Our aim was to describe clinical case which represent our first experience of performing multiple corporal incisions through innovative subcoronoral approach without subsequent substitution of tunica albuginea. As a result of graft-free technique an effective penile straightening was achieved after three-piece prosthesis implantation with good long-term functional and cosmetic results. The first experience of graft-free technique of corporotomy during penile prosthesis implantation through subcoronal approach suggests its potential efficacy and safety in patients with a combination of ED and Peyronie disease.
Collapse
Affiliation(s)
- N D Akhvlediani
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A N Bernikov
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A S Chernushenko
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - I A Reva
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Clinical medical center of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
30
|
Pushkar DY, Kasyan GR, Dzhuraeva MD. [Suprapubic cartilaginous cyst]. Urologiia 2019:122-123. [PMID: 31356024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Suprapubic cartilaginous cyst represents a rare disease. Considering its low prevalence, only 9 clinical case have been described in literature. This lesion is often overlooked due to absence of clinical manifestations, incomplete diagnosis or the lack of necessary information about the disease. We observed a 74-year-old woman whose diagnosis of suprapubic cartilaginous cyst was confirmed by biopsy, as well as ultrasound, computer tomography and MRI results.
Collapse
Affiliation(s)
- D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - G R Kasyan
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - M D Dzhuraeva
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
31
|
Pushkar DY, Rasner PI, Kotenko DV, Gerasimov AN, Shabalkin SA. [Treatment of patients with lower urinary tract symptoms in Moscow]. Urologiia 2019:7-12. [PMID: 31356007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
INTRODUCTION In recent years, there has been a persistent tendency to a decrease in surgical treatment of patients with lower urinary symptoms (LUTS). This fact can be explained by variety drugs which have acceptable safety and high efficiency for treatment of urinary disorders. As part of our survey of men in Moscow region, the trends in prescribing the different drugs for the LUTS was studied. In addition, the duration of therapy and patient adherence were analyzed. MATERIALS AND METHODS A prospective multicenter epidemiological study "Characteristics of lower urinary tract symptoms in men in the Moscow region" was carried out using data obtained from April 1 to May 31, 2017 with anonymous survey of 525 men with mean age of 64.2+/-9.93 years, living in Moscow and went to the urologist with urinary disorders. All respondents answered questions from specially designed questionnaire consisted from 140 items. All medical data were analyzed, including received drugs, the duration of the therapy and subjective assessment of efficiency. RESULTS A total of 419 patients from 525 (79.8%) received any kind of therapy. The most commonly used drugs were -blockers, which consisted 65% of all prescriptions. Other drugs were administered significantly rarely. It is surprisingly, that 85.6% of respondents in Moscow region received the original -blockers, not generic drugs. Satisfaction rate was 74.3%. Most of patients (58.3%) had received -blockers for 1-3 years and 33.3% administered these drugs for more than 3 years. Combined drug therapy was the second most popular (25.5%). The most commonly used combination included -blockers and inhibitors of 5-reductase. In 90.6% cases the appointment was made by urologist. CONCLUSION Drug therapy is the most popular treatment in patients with LUTS. Our data suggest that -blockers as monotherapy or in combination with inhibitors of 5-reductase is the most often prescribed therapy. These results are in concordance with the main conclusions of international studies dedicated to this issue.
Collapse
Affiliation(s)
- D Yu Pushkar
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Department of Medical informatics and statistics of I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | - P I Rasner
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Department of Medical informatics and statistics of I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | - D V Kotenko
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Department of Medical informatics and statistics of I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | - A N Gerasimov
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Department of Medical informatics and statistics of I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | - S A Shabalkin
- Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- Department of Medical informatics and statistics of I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| |
Collapse
|
32
|
Nikitina AS, Sharova EI, Danilenko SA, Selezneva OV, Skorodumova LO, Kanygina AV, Babalyan KA, Vasiliev AO, Govorov AV, Prilepskaya EA, Pushkar DY, Kostryukova ES, Generozov EV. Data on somatic mutations obtained by whole exome sequencing of FFPE tissue samples from Russian patients with prostate cancer. Data Brief 2019; 25:104022. [PMID: 31223638 PMCID: PMC6565602 DOI: 10.1016/j.dib.2019.104022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2019] [Revised: 04/24/2019] [Accepted: 05/13/2019] [Indexed: 11/28/2022] Open
Abstract
Prostate cancer (PCa) is the most frequently diagnosed among men malignant disease that remains poorly characterized at the molecular level. Advanced PCa is not curable, and the current treatment methods can only increase the life expectancy by several months. Identification of the genetic aberrations in tumor cells provides clues to understanding the mechanisms of PCa pathogenesis and the basis for developing new therapeutic approaches. Here we present data on somatic mutations, namely single nucleotide variations (SNVs), small insertions and deletions, detected in prostate tumor tissue obtained from Russian patients with PCa. Moreover, we provide a raw dataset on the whole exome and targeted DNA sequencing of tumor and non-tumor prostate tissue obtained from Russian patients with PCa and benign prostatic hyperplasia (BPH). This data is available at NCBI Sequence Read Archive under Accession No. PRJNA506922.
Collapse
Affiliation(s)
- A S Nikitina
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.,Moscow Institute of Physics and Technology, Dolgoprudnyi, Russia
| | - E I Sharova
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| | - S A Danilenko
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| | - O V Selezneva
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| | - L O Skorodumova
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| | - A V Kanygina
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| | - K A Babalyan
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| | - A O Vasiliev
- Department of Urology, Moscow State Medical Stomatological University, Moscow, Russia
| | - A V Govorov
- Department of Urology, Moscow State Medical Stomatological University, Moscow, Russia
| | - E A Prilepskaya
- Department of Urology, Moscow State Medical Stomatological University, Moscow, Russia
| | - D Y Pushkar
- Department of Urology, Moscow State Medical Stomatological University, Moscow, Russia
| | - E S Kostryukova
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| | - E V Generozov
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
| |
Collapse
|
33
|
Abstract
Robot-assisted surgery is one of the most important achievements of modern medicine. Robot-assisted operations widely used in urology, gynecology, general and cardiovascular surgery are considered by many experts as a new 'gold standard' of surgical treatment of various diseases in developed countries. Well-known advantages of robot-assisted surgery are low invasiveness, 3D-visualization of surgical field, high accuracy of instrument movements resulting minimal intraoperative blood loss, short hospital-stay, rapid recovery and short social maladjustment of operated patients. Robot-assisted radical prostatectomy in patients with prostate cancer is the most common robotic procedure worldwide. Better functional outcomes are due to another (new) understanding of pelvic surgical anatomy, changed approach to dissection and preservation of external urethral sphincter and neurovascular bundles. Prostate neuroanatomy, various variants of preservation of neurovascular bundles are reviewed in the article. Moreover, own experience of robot-assisted radical prostatectomy followed by favorable functional results is presented.
Collapse
Affiliation(s)
- D Yu Pushkar
- Urology Department A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - K B Kolontarev
- Urology Department A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
34
|
Pushkar DY, Kolontarev KB. [Robot-assisted radical prostatectomy. Functional result. Part I. (in Russian only)]. Khirurgiia (Mosk) 2019:111-120. [PMID: 30938366 DOI: 10.17116/hirurgia2019031111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Robot-assisted operations as widely used in urology, gynecology, general and cardiovascular surgery are considered by many experts as a new 'gold standard' of surgical treatment of various diseases in developed countries. Robot-assisted radical prostatectomy for prostate cancer is the most common robotic procedure. Better functional outcomes of robot-assisted radical prostatectomy are due to another (new) understanding of pelvic surgical anatomy, new approach implying dissection and preservation of external urethral sphincter and neurovascular structures. Prostate neuroanatomy, various approaches to preserve neurovascular structures and own experience of nerve-sparing robot-assisted radical prostatectomy with functional results are reviewed in the article.
Collapse
Affiliation(s)
- D Yu Pushkar
- Chair of Urology, Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of the Russia, Moscow, Russia
| | - K B Kolontarev
- Chair of Urology, Evdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of the Russia, Moscow, Russia
| |
Collapse
|
35
|
Pushkar DY, Rasner PI, Aboyan IA, Asfandiyarov FR, Kotov SV, Kogan MI, Korneev IA, Medvedev VL, Neymark AI, Novikov AI, Pavlov VN, Tsukanov AY, Shabalkin SA, Shormanov IS. [LUTS/BPH who treats? The results of the epidemiologic study]. Urologiia 2019:5-15. [PMID: 31184011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
INTRODUCTION In this study an attempt was made to determine some reasons that prompted the urologist to make a choice in favor of particular drug or combination from a wide variety of available drugs. The prescribing habits and subjective evaluation of efficiency and safety of the drugs for the treatment of lower urinary tract symptoms/benign prostatic hyperplasia by the urologists in Russia was analyzed. MATERIALS AND METHODS a prospective multicenter epidemiological study "LUTS/BPH - who treats?" was carried out in 12 centers using data obtained from May 1 to July 31, 2018 with anonymous survey of 500 urologists living in 9 cities of the Russian Federation. The survey consisted of 46 questions reflecting a level of education, involvement in scientific life of urologic community, membership in various professional organizations, and subjective assessment of safety and efficiency of drugs used in Russian Federation for the treatment of urinary disorders. The obtained data was analyzed for a whole group and further in the subgroups. RESULTS Alpha-blockers are the most commonly prescribed drugs. These drugs constitute 63.4% of all appointments, followed by the 5-a-reductase inhibitors (23.98%) and combined therapy by the both drugs (24.68%). The most frequently used alpha-blocker is tamsulosin, but professors, MD and urologists, who read special literature at a regular basis, prescribed tamsulosin and silodosin equally. In primary cases and in patients with concomitant cardiac pathology, silodosin was prescribed more commonly in comparison with other alpha-blockers. CONCLUSION the results of the study indicate a concordance with global trends in the treatment of these patients. Our data reflect a significant influence of the level of education, work experience and involvement in scientific professional life of urologic community on the choice of a particular drug for the treatment of LUTS/BPH and prove the feasibility of further work which should be aimed at popularization of the modern medical knowledges among the urologists and organization of a process of continuous medical education.
Collapse
|
36
|
Pushkar DY, Gadgieva ZK, Kasyan GR, Krivoborodov GG, Kupriyanov YA, Rosier PF. [Good urodynamic practice: consensus on the terminology]. Urologiia 2019:131-136. [PMID: 31184031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
In this publication a summary of the published manuscript "Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study" developed by a working group under the guidance of the Standardization Steering Committee of International Continence Society (ICS)1 is presented. The members of the working group were: Werner Schaefer, Gunnar Lose, Howard B. Goldman, Michael Guralnick, Sharon Eustice, Tamara Dickinson, Hashim Hashim and Peter F.W.M Rosier.
Collapse
Affiliation(s)
- D Yu Pushkar
- ) Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- ) FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- ) Department of Urology and Andrology in N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- ) University Medical Center Utrecht, Netherlands
| | - Z K Gadgieva
- ) Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- ) FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- ) Department of Urology and Andrology in N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- ) University Medical Center Utrecht, Netherlands
| | - G R Kasyan
- ) Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- ) FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- ) Department of Urology and Andrology in N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- ) University Medical Center Utrecht, Netherlands
| | - G G Krivoborodov
- ) Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- ) FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- ) Department of Urology and Andrology in N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- ) University Medical Center Utrecht, Netherlands
| | - Yu A Kupriyanov
- ) Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- ) FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- ) Department of Urology and Andrology in N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- ) University Medical Center Utrecht, Netherlands
| | - P F Rosier
- ) Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- ) FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
- ) Department of Urology and Andrology in N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- ) University Medical Center Utrecht, Netherlands
| |
Collapse
|
37
|
Rasner PI, Vasilyev AO, Govorov AV, Pushkar DY, Pushkarev AV, Shakurov AV, Tsiganov DI, Zherdev AA. [One-stage cryoablation of two renal tumors]. Khirurgiia (Mosk) 2019:95-100. [PMID: 30789616 DOI: 10.17116/hirurgia201901195] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The progressive development of medical technologies allowed the introduction of alternative methods of treatment of localized renal cell carcinoma with a tendency to organ-sparing approach. Cryoablation, radiofrequency ablation, and some experimental methods of treatment (microwave and laser ablation, therapy with high-intensity focused ultrasound) are referred to minimally invasive treatment of renal cell carcinoma. Cryoablation is highly effective alternative method of treatment of renal cell carcinoma. The main advantages of this technique are tumor visualization and formation of 'ice ball' in real time, fewer complications compared with other methods, as well as the possibility of cryotherapy in critically ill patients. Compared to other ablative technologies, cryoablation is followed by low percentage of redo treatment and good intermediate oncological results. We described the experience of one-stage cryoablation of two kidney tumors in this report.
Collapse
Affiliation(s)
- P I Rasner
- Department of Urology of the Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A O Vasilyev
- Department of Urology of the Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A V Govorov
- Department of Urology of the Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of the Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A V Pushkarev
- Bauman Moscow State Technical University, Moscow, Russia
| | - A V Shakurov
- Bauman Moscow State Technical University, Moscow, Russia
| | - D I Tsiganov
- Bauman Moscow State Technical University, Moscow, Russia
| | - A A Zherdev
- Bauman Moscow State Technical University, Moscow, Russia
| |
Collapse
|
38
|
Al-Shukri SH, Pushkar DY, Apolikhin OI, Evdokimov MS, Kogan MI, Krivoborodov GG, Kagan OF, Petrov SB, Poltoratskyi AN, Kuzmin IV, Sharvadze GG. [Imidafenacin for treatment of overactive bladder and urgent urinary incontinence: the results of open-label multicenter randomized controlled clinical trial]. Urologiia 2018:20-25. [PMID: 30742373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
INTRODUCTION The analysis of the results of a multicenter, open, randomized comparative phase III clinical trial on the use of imidafenacin for treating patients with OAB was carried out. A clinical study was conducted according to GCP standards in 12 urological centers of the Russian Federation with the support of company AO "R-Pharm". MATERIALS AND METHODS A total of 296 patients (men and women) aged from 18 to 65 years with OAB and urgent urinary incontinence were included in the study. All patients were randomized into two groups. In Group 1 (n=148) patients received -cholinoblocker imidafenacin 1 tablet (0,1 mg) twice a day. Group 2 patients (n=148) were prescribed a comparison drug tolterodine 1 tablet (2 mg) twice a day, as well. The duration of treatment was 12 weeks. RESULTS The analysis of results showed a significant decrease in the OAB symptoms in both groups. In Group 1 a decrease of episodes of urge urinary incontinence was more pronounce compared to Group 2, as well as amount of day-time and night-time of episodes of urge urinary incontinence by the 2nd, 4th, 8th and 12th weeks of treatment in comparison with baseline scores. There were no differences between two groups in the severity of reducing average urinary frequency per day. Reducing the severity of urinary disturbances in patients of both groups was accompanied by an improvement in the quality of life. There was a significant and similar decrease in the average total score of both OAB Awareness Tool and EQ-5D questionnaires. Tolerability of treatment was satisfactory in both groups and there were no differences in the adverse events in Group 1 and 2. CONCLUSION Imidafenacin showed high clinical efficacy for treating patients with OAB, which is not inferior, and in some values, is superior in comparison to tolterodine. Both drugs had a similar safety and tolerability profile.
Collapse
Affiliation(s)
- S H Al-Shukri
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - D Yu Pushkar
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - O I Apolikhin
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - M S Evdokimov
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - M I Kogan
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - G G Krivoborodov
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - O F Kagan
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - S B Petrov
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - A N Poltoratskyi
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - I V Kuzmin
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| | - G G Sharvadze
- FGBOU VO Pavlov First Saint Petersburg State Medical University of Minzdrav of Russia, Saint Petersburg, Russia
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of Minzdrav of Russia, Moscow, Russia
- FGBU The National Medical Research Radiologic Center of Minzdrav of Russia, Moscow, Russia
- Family Policlinic 4 LLC, Moscow, Russia
- FGBOU VO Rostov State Medical University of Minzdrav of Russia, Rostov-on-Don, Russia
- N.I. Pirogov RNRMU of Minzdrav of Russia, Moscow, Russia
- Hospital Orkli LTD, Saint Petersburg, Russia
- FGBU All-Russian Centre of Emergency and Radiation Medicine named after A.M. Nikiforov of the Emergency of Russia
- Baltic Medicine LTD , Saint Petersburg, Russia
- AO R-Farm, Moscow, Russia
| |
Collapse
|
39
|
Sukhikh SO, Kolontarev KB, Vasilyev AO, Pushkar DY. [Robot-assisted pelvic floor reconstruction: review and own experience]. Urologiia 2018:139-143. [PMID: 30742393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Pelvic organ prolapse (POP) is the most common urogynecological disease in women of middle and older age groups. This disease causes numerous urogenital symptoms and significantly reduces the quality of life of patients. Surgical correction of POP is the optimal method f treatment for this category of patients, however, the choice of surgery and access remains controversial. In recent decades, thanks to the development of robotic technologies, the use of robot-assisted sacrocolpopexy (RAS) has become increasingly popular. Numerous studies have shown the equivalence of results compared with the "gold standard" repair of prolapse - open sacrocolpopexy. This article presents a review of the current literature and our own experience of RAS.
Collapse
Affiliation(s)
- S O Sukhikh
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - K B Kolontarev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A O Vasilyev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
40
|
Vasilyev AO, Govorov AV, Shiryaev AA, Bykov PI, Kim Yu A, Kalinina NA, Schneiderman MG, Pushkar DY. [Evaluation bacteriological analysis of urine in patients with long-term bladder drainage]. Urologiia 2018:26-31. [PMID: 30742374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
INTRODUCTION The experience of comparative evaluation of the effectiveness of various types of urethral catheters in prevention of catheter-associated infection is described in this article. MATERIALS AND METHODS The study included 69 patients treated at the CCH n.a. S.I. Spasokukotsky in the period from December 2017 to March 2018. The average age of patients was 67.5 years. In all patients, the bladder was drained by a two-way Foley catheter No. 16-18 Ch (100% silicone). In the 1st group (n=18), the bladder was drained with a standard urethral uncoated catheter, in the 2nd (n=16) - with a silver impregnated urethral catheter, in the 3rd (n=15) - with an urethral catheter coated with nitrofuran, in the 4th (n=20) urethral catheter with the possibility of controlled irrigation of the bladder and urethra with antiseptic solutions and (a new model of the urethral catheter developed during cooperative work of the Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov Urology Department and National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov). RESULTS The bladder was drained by Foley urethral catheter for more or equal 15 days. A microbiological study of urine (on the example of clinical isolates of conditionally pathogenic microorganisms) with preparation of an inoculum, inoculation of nutrient media, counting cultures of pathogenic bacteria and determining the sensitivity of pathogenic bacteria to antibiotics was carried out. The study showed the effectiveness of the new urethral catheter model in patients with long-term bladder drainage. CONCLUSIONS Conducting multicenter studies evaluating the effectiveness of the proposed urethral catheter model with the inclusion of a larger number of patients will reduce the economic costs, associated with treating patients with prolonged bladder drainage in the long term by reducing the number of nosocomial infection cases and reducing postoperative day.
Collapse
Affiliation(s)
- A O Vasilyev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| | - A V Govorov
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| | - A A Shiryaev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| | - P I Bykov
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| | - A Kim Yu
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| | - N A Kalinina
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| | - M G Schneiderman
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov, Moscow, Russia
- S.I. Spasokukotsky City Clinical Hospital, Moscow, Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology n.a. V.I. Kulakov, Moscow, Russia
| |
Collapse
|
41
|
Kupriyanov YA, Kasyan GR, Pushkar DY. [A role of fesoterodine in treatment of overactive bladder]. Urologiia 2018:155-162. [PMID: 30742396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The muscarinic receptors have been used as target in treatment of overactive bladder (OAB) for a long time. These patients have complaints of urgency, increased urinary frequency and nocturia, sometimes with urinary incontinence (involuntary urine leakage which is associated with abrupt and strong desire to void). Fesoterodine is a prodrug that is structurally and functionally associated with tolterodine and it is the novel drug for OAB treatment. As a result of fesoterodine cleavage by non-specific esterase, the active metabolite 5-hydroxymethyl tolterodine (5-HMT) is formed. Like other antimuscarinic drugs, fesoterodine allows to improve bladder storage function (reducing the frequency of urination) and urgency. For assessing an improvement of the quality of life after treatment by fesoterodine the KHQ questionnaire was used.
Collapse
Affiliation(s)
- Yu A Kupriyanov
- Department of Urology of Federal State Budgetary Educational Institution of Higher Education A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| | - G R Kasyan
- Department of Urology of Federal State Budgetary Educational Institution of Higher Education A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology of Federal State Budgetary Educational Institution of Higher Education A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| |
Collapse
|
42
|
Pushkar DY, Kasyan GR, Potapova LV, Sukhikh SO, Dzhuraeva MD. [Lower urinary tract symptoms among women in the Russian Federation: data from an online survey]. Urologiia 2018:5-8. [PMID: 30761782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
AIM To estimate the prevalence and severity of lower urinary tract symptoms in the female population using a LUTS-specific questionnaire. MATERIALS AND METHODS The study analyzed the prevalence of LUTS in the population of women residing in the Russian Federation. Information about voiding disorders in women, which was announced on federal television health-related programs, was posted on the website of the medical portal zdorovieinfo.ru. All questionnaires were filled in by the patients anonymously. The questionnaire was prepared by the editors of the website. We analyzed the survey results. RESULTS After the TV announcement, the survey website was visited by more than 15,000 people. Of them, 2,600 people filled the questionnaire (17% of the number of visitors). The findings of the survey suitable for the analysis were obtained from 2419 women (93.07%) and 181 men (6.93%). The mean age of female participants was 55 years old. CONCLUSION The study had some limitations and was not truly epidemiological, as it involved only those women who had information and technical access to the Internet portal and questionnaires. Despite this, the findings suggest the high prevalence of LUTS among women in our country.
Collapse
Affiliation(s)
- D Yu Pushkar
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - G R Kasyan
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - L V Potapova
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - S O Sukhikh
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - M D Dzhuraeva
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
43
|
Pushkar DY, Rasner PI, Kotenko DV, Gerasimov AN, Shabalkin SA. [Specific features of lower urinary tract symptoms in men living in the moscow region. Results of the epidemiological study]. Urologiia 2018:20-29. [PMID: 30035414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
INTRODUCTION Voiding disorders in men are manifested by various symptoms associated with impairment of the urinary flow along the urinary tract and worsening of the urinary bladder storage function. There is a considerable lack of data on the prevalence of LUTS, their severity, and correlation with data from objective studies in men in the Russian Federation in general and in the Moscow region in particular. MATERIALS AND METHODS A prospective multicenter epidemiological study "Specific Features of Lower Urinary Tract Symptoms in Men Living in the Moscow Region" was conducted based on data acquired from April 1 to May 31, 2017 by an anonymous survey of 525 men (mean age 64.2+/-9.93 years old), residing in Moscow and presenting with complaints of urination disorders. The respondents answered questions of a specially developed 140-item questionnaire. All demographic and medical information was taken into account, including concomitant diseases and ongoing therapy. The patients filled out the IIEF, I-PSS, QoL, and AMS (Aging Male Screening) questionnaires. RESULTS Analysis the I-PSS scores showed that symptoms of the emptying phase predominated over the symptoms of the filling phase in all age groups. The most frequent complaints were "frequent urination" and "weak urine stream". Forty and 30% of respondents had moderate and severe LUTS, respectively. The remaining 30% of men had mild LUTS. Prostate volume was significantly greater than that reported in similar studies conducted in Asia, Europe and North America (mean 55.27 cm3). The level of total prostate-specific antigen (PSA) was known in 98.8% of patients over the age of 50 and averaged 3.87+/-4.41 ng/ml. The mean age at the first testing for total PSA in Moscow is 56.7+/-9.0 years. CONCLUSION This study is the first epidemiological study of this scale and focus. Its findings can be used to compose a "portrait" of a standard patient and identify patterns that limit the extrapolation of international epidemiological studies to the population of Russian patients. It seems necessary to develop an updated LUTS management strategy, taking into account the identified national characteristics.
Collapse
Affiliation(s)
- D Yu Pushkar
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
- Department of Medical Informatics and Statistics, the Faculty of Medicine and Prevention, I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia
| | - P I Rasner
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
- Department of Medical Informatics and Statistics, the Faculty of Medicine and Prevention, I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia
| | - D V Kotenko
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
- Department of Medical Informatics and Statistics, the Faculty of Medicine and Prevention, I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia
| | - A N Gerasimov
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
- Department of Medical Informatics and Statistics, the Faculty of Medicine and Prevention, I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia
| | - S A Shabalkin
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
- Department of Medical Informatics and Statistics, the Faculty of Medicine and Prevention, I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia
| |
Collapse
|
44
|
Pushkar DY, Govorov AV, Rasner PI, Kolontarev KB. [The role of simulators in teaching for robot-assisted surgery]. Khirurgiia (Mosk) 2018:82-88. [PMID: 29560965 DOI: 10.17116/hirurgia2018382-88] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- D Yu Pushkar
- Department of Urology, Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - A V Govorov
- Department of Urology, Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - P I Rasner
- Department of Urology, Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| | - K B Kolontarev
- Department of Urology, Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
| |
Collapse
|
45
|
Pushkar DY, Bernikov AN, Khodyreva LA, Dudareva AA, Al'-Shukri SK, Amdii RE, Aboyan IA, Shiranov KA, Medvedev VL, Efremov ME. [Quality of life in patients with lower urinary tract symptoms after TURP for benign prostatic hyperplasia]. Urologiia 2018:53-61. [PMID: 29634135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
INTRODUCTION To date, the gold standard for the surgical management of BPH is transurethral resection of the prostate (TURP). Most patients who undergo TURP for BPH experience immediate effects and complete relief of lower urinary tract symptoms and do not need further urological care. However, some patients after this operation have some level of persistent residual lower urinary tract symptoms, which may require additional therapy. AIM To investigate voiding function and the need for medical therapy in patients who underwent TURP for LUTS due to BPH. MATERIALS AND METHODS This study was performed as an anonymous survey among male patients presenting to a urology clinic. During the visit, the patients were offered to fill out I-PSS and SF-36 questionnaires. Also, they were asked about their socio-economic status, history of BPH, their perception of surgery and the postoperative period up to the day of the interview, presence or absence of symptoms of voiding dysfunction and any drug therapy at the time of the interview or after surgery. The patients also rated the severity of the symptoms using the IPSS questionnaire. The study comprised patients after 12 months to 3 years following successful TURP for LUTS due to BPH. A total of 1100 questionnaires were forwarded to researchers for interviewing patients who underwent TURP for prostatic hyperplasia. RESULTS After collecting and reviewing all the questionnaires, 921 questionnaires were found eligible. The findings of the survey showed that a significant proportion of patients who underwent TURP require a long-term postoperative medical therapy. At the same time, in the Russian Federation, there are no standard approaches to medical management of this category of patients.
Collapse
Affiliation(s)
- D Yu Pushkar
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - A N Bernikov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - L A Khodyreva
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - A A Dudareva
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - S Kh Al'-Shukri
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - R E Amdii
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - I A Aboyan
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - K A Shiranov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - V L Medvedev
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| | - M E Efremov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia
- Medical-diagnostic center Zdorov'e, Rostov-on-Don, Russia
- Kuban State Medical University, Krasnodar, Russia
- Research Institute of Public Health and Medical Management of the MHD, Moscow, Russia
| |
Collapse
|
46
|
Vasiliyev AO, Shiryaev AA, Govorov AV, Kolontarev KB, Rasner PI, Dyakov VV, Semenyakin IV, Pushkar DY. [Intestinal obstruction in early postoperative period after robot-assisted prostatectomy]. Khirurgiia (Mosk) 2018:90-93. [PMID: 29697691 DOI: 10.17116/hirurgia2018490-93] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Affiliation(s)
- A O Vasiliyev
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - A A Shiryaev
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - A V Govorov
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - K B Kolontarev
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - P I Rasner
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - V V Dyakov
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - I V Semenyakin
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| |
Collapse
|
47
|
Kasyan GR, Sukhikh SO, Pushkar DY. [The place of mirabegron in clinical practice]. Urologiia 2017:144-148. [PMID: 29376612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Currently, a wide range of different drugs is available for te management of overactive bladder. This creates problems when it comes to drug selection and personalized care for each patient. Mirabegron is the only 3-adrenomimetic agent for the treatment of urinary disorders, which, after careful long-term multi-center randomized trials, has been approved for use in Europe and North America. Mirabegron has proven to be very effective in patients who had previously received anticholinergic drugs and discontinued them because of the insufficient therapeutic effect or pronounced adverse reactions. However, the question of using Mirabegron as a first-line treatment for overactive bladder and the existing limitations in its administration in clinical urology practice remains open.
Collapse
Affiliation(s)
- G R Kasyan
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
| | - S O Sukhikh
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, A.I. Evdokimov MSUMD, Moscow, Russia
| |
Collapse
|
48
|
Vasilyev AO, Govorov AV, Shiryaev AA, Pushkar DY. [The role of the uretral catheter in the development of catheter- related urinary tract infection]. Urologiia 2017:107-111. [PMID: 29376606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The most common source of nosocomial infection is the urinary tract, especially if they it is drained with a urethral catheter. Catheter-associated urinary tract infections account for at least 80% of all complicated urinary tract infections and are the most common type of hospital-acquired infection. Intestinal microflora plays the leading role in the pathogenesis of catheter-associated urinary tract infections, whereas the most important risk factor for their development is the long duration of urinary catheter drainage. In the case of short-term and intermittent catheterization, routine antibiotic prophylaxis is not required, but if a patient develops clinically significant infection, antibiotic therapy is required followed by definitive therapy based on culture. Urethral catheters coated with antimicrobial substances and anti-inflammatory agents can significantly reduce the adhesion and migration of bacteria, thereby reducing the incidence of urinary tract infections. Despite this, the incidence of catheter-associated infection remains high. We have reviewed recent literature related to catheter-associated urinary tract infections and the best means of preventing this condition.
Collapse
Affiliation(s)
- A O Vasilyev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Moscow, Russia
| | - A V Govorov
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Moscow, Russia
| | - A A Shiryaev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Moscow, Russia
| |
Collapse
|
49
|
Govorov AV, Vasilyev AO, Shiryaev AA, Sukhikh SO, Sidorenkov AV, Pushkarev AV, Tsiganov DI, Pushkar DY. [Current methods of early diagnosis of prostate cancer]. Urologiia 2017:101-106. [PMID: 29376605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Prostate cancer is the most common cancer among men, except for lung cancer. Therefore, it is imperative to identify diagnostic methods for early detection of prostate cancer to determine patients from healthy populations, which helps guide a timely treatment at an initial stage of the disease. The article provides an in-depth review of the most current diagnostic biomarkers of prostate cancer, their role in clinical practice as a means of the early detection and screening for prostate cancer.
Collapse
Affiliation(s)
- A V Govorov
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| | - A O Vasilyev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| | - A A Shiryaev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| | - S O Sukhikh
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| | - A V Sidorenkov
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| | - A V Pushkarev
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| | - D I Tsiganov
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
- S.I. Spasokukotsky Municipal Clinical Hospital, Moscow, Russia
- Energomashinostroenie Research Institute, N.E. Bauman Moscow State Technical University, Moscow, Russia
| |
Collapse
|
50
|
Govorov AV, Vasilyev AO, Pushkar DY. [Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer]. Urologiia 2017:37-41. [PMID: 28952690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
RELEVANCE From the moment of their first use to the present day, -adrenoblockers remain the most popular medication in urology. Indications for their clinical use for various pathological conditions are constantly expanding. AIM To compare the efficacy of androgen deprivation therapy (ADT) alone and ADT with concomitant use of tamsulosin in treating lower urinary tract symptoms (LUTS), and to estimate the efficacy and safety of tamsulosin in relieving voiding dysfunction symptoms in patients with advanced PCa treated for 6 months. MATERIALS AND METHODS This paper presents data from a randomized, open, single-center trial that evaluated the efficacy and safety of tamsulosin co-administered with ADT for LUTS in patients with advanced prostate cancer. The study comprised 50 people aged below 75 years. In the first group of patients (n=25), ADT was used as a monotherapy, in the second group (n=25) ADT with concurrent administration of the -adrenoblocker. The duration of treatment was 6 months. RESULTS Both groups showed an improvement in the severity of LUTS, decrease in the total I-PSS score and residual urine volume and increase in the urinary flow rate. At the same time, co-administration of ADT and -adrenoblocker resulted in greater and faster relief of LUTS than using ADT alone. There were no significant side effects in any of the groups. CONCLUSIONS Co-administration of ADT and the -blocker is an effective and safe treatment for advanced prostate cancer in patients with LUTS.
Collapse
Affiliation(s)
- A V Govorov
- Department of Urology, Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - A O Vasilyev
- Department of Urology, Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| | - D Yu Pushkar
- Department of Urology, Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia
| |
Collapse
|